eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

CSL Behring UK Limited
Hayworth House, Market Place, Haywards Heath, West Sussex, RH16 1DB, UK
Telephone: +44 (0)1444 447 400
Fax: +44 (0)1444 447 403
WWW: http://www.cslbehring.co.uk
Medical Information Direct Line: +44 (0)1444 447 405
Medical Information e-mail: medinfo@cslbehring.com
Customer Care direct line: +44 (0)1444 447 402
Out of Hours contact: +44 (0)1444 447 405

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 29/09/2011
PIL Mononine

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 29/09/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Unknown
Updated on 18/02/2009 and displayed until 29/09/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 25/04/2008 and displayed until 18/02/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 22/10/2007 and displayed until 25/04/2008
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 18/10/2007 and displayed until 22/10/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 18/10/2007 and displayed until 18/10/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 24/08/2007 and displayed until 18/10/2007
Reasons for adding or updating:
  • Company name change or merger
Updated on 26/06/2006 and displayed until 24/08/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 23/06/2006 and displayed until 26/06/2006
Reasons for adding or updating:
  • PIL Retired combination of strengths
Updated on 11/05/2004 and displayed until 23/06/2006
Reasons for adding or updating:
  • PIL Company name change or merger
  • Change of manufacturer
  • Change to warnings or special precautions for use
  • Change to, or new, use for medicine
  • Change to side-effects
  • Change to instructions about overdose
  • Change to date of revision
Updated on 30/08/2002 and displayed until 11/05/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 27/09/2001 and displayed until 30/08/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 06/09/2000 and displayed until 27/09/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  factor IX